LAB.00049 Artificial Intelligence-Based Software for Prostate Cancer Detection

- Service addressed: Artificial intelligence-based software used for prostate cancer detection (e.g., algorithms applied to digital pathology whole-slide images). - Coverage: Anthem considers this technology investigational/experimental and not medically necessary; it is not covered for any indication. - Limitations: The noncoverage applies to all clinical scenarios and uses (standalone or adjunctive), including services that might be billed under CPT 88399.

"Use of artificial intelligence-based software for prostate cancer detection is consideredinvestigational and not medically necessaryfor all indications."

Sign up to see full coverage criteria, indications, and limitations.